Navigation Links
Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
Date:1/13/2009

WILMINGTON, N.C., Jan. 13 /PRNewswire/ -- Inclinix, Inc., a clinical trial enrollment solutions provider, announces the release of its next generation Critical Population Research(R) (CPR) system. A proprietary technology that integrates numerous public and private databases, CPR analyzes each investigator site for multiple criteria to identify the optimal sites for clinical trials. The CPR database has been expanded to include profiles on 40,000 additional investigators, now totaling over 100,000, including thousands of international investigators. This international capacity provides sponsors with a global analysis of prospective sites.

Critical Population Research identifies where patients with a specific condition are concentrated by providing color-coded maps of disease prevalence from national to ZIP code level. These maps identify clusters of sites that maximize media budgets and even provide visual insight into geographic barriers to clinical trial participation, such as availability of public transportation or parking. Inclinix's Media Optimizer uses this aspect of CPR as its foundation, implementing only the most effective and cost-efficient patient outreach for each site. This process, complemented by the extensive CPR investigator database, provides a powerful dataset for site selection and patient recruitment.

"The clinical trials industry has repeatedly identified site initiation as a primary cause of delays," explains J. Tobin Geatz, Inclinix President and CEO. "Our enhanced CPR technology offers our clients a proven, scientific solution to investigator site selection. By initiating only the most qualified investigators who have access to the right patients, trials will enroll - and ultimately complete - faster and at less cost."

In a three-year retrospective analysis of multiple trials, Inclinix found that investigators located in CPR "hot zones" (areas of high disease prevalence) enrolled at a rate nearly three times faster than those located in "cold zones" (areas of low disease prevalence). This data-driven approach to site selection results in identification of the most qualified investigators, leading to faster, more effective patient recruitment and trial completion.

About Inclinix

Inclinix, Inc. specializes in customized Phase I-IV clinical trial enrollment solutions that deliver productive investigator sites and qualified patients for the pharmaceutical, biotech and medical device industry. Clients benefit from ten years of experience in multiple therapeutic areas, as well as leading edge technologies that meet the challenge of clinical development from feasibility through compliance.

For more information, visit www.inclinix.com.


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Inclinix Announces New Patent for Expert System Platform
2. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
3. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
4. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
5. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
6. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
7. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
8. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the device ... care market in Israel   ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Empty Capsules Market is poised to grow at a CAGR ... by 2025. This industry report analyzes the market estimates ... regional levels presented in the research scope. The study provides historical market ...
(Date:2/24/2017)... Pa. , Feb. 24, 2017 Physician ... of Drug and Alcohol Programs Jennifer Smith ... in providing training for and using naloxone, a life-saving ... Mark McCullough , a recovery specialist and overdose survivor ... by EMS providers. "A significant part of ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... qualifying into the Senior International Elite division on February 12th. Ms. Esparza ... divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida is ...
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
(Date:2/23/2017)... ... ... The 89th Academy Awards will be celebrated this weekend, which means it’s ... Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the shoddiest ... for American Progress (CAP), for its report, Lessons From State Performance on NAEP: Why ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... media outlet with a clinician-based audience, will be participating in Rare Disease Day ... in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
Breaking Medicine News(10 mins):